Key Qualities of TILs & Hallmarks of Successfully Developing TIL Therapies
Time: 9:15 am
day: Conference Day Two
Details:
- Highlighting advantages of TIL poly-clonality and state-of-the-art approaches such as AI/ML to obtain and preserve truly tumor reactive T-cells
- Identifying gene-modifications to enhance TIL expansion, persistence, and efficacy
- Discussing current innovations in cell culture methods for effective TIL expansion
